Early identification of stimulant treatment responders, partial responders and non-responders using objective measures in children and adolescents with hyperkinetic disorder
- PMID: 32847239
- DOI: 10.1111/j.1475-3588.2010.00593.x
Early identification of stimulant treatment responders, partial responders and non-responders using objective measures in children and adolescents with hyperkinetic disorder
Abstract
Background: The aim of this study was to evaluate stimulant medication response following a single dose of methylphenidate (MPH) in children and young people with hyperkinetic disorder using infrared motion analysis combined with a continuous performance task (QbTest system) as objective measures. The hypothesis was put forward that a moderate testdose of stimulant medication could determine a robust treatment response, partial response and non-response in relation to activity, attention and impulse control measures.
Methods: The study included 44 children and young people between the ages of 7-18 years with a diagnosis of hyperkinetic disorder (F90 & F90.1). A single dose-protocol incorporated the time course effects of both immediate release MPH and extended-release MPH (Concerta XL, Equasym XL) to determine comparable peak efficacy periods post intake.
Results: A robust treatment response with objective measures reverting to the population mean was found in 37 participants (84%). Three participants (7%) demonstrated a partial response to MPH and four participants (9%) were determined as non-responders due to deteriorating activity measures together with no improvements in attention and impulse control measures.
Conclusion: Objective measures provide early into prescribing the opportunity to measure treatment response and monitor adverse reactions to stimulant medication. Most treatment responders demonstrated an effective response to MPH on a moderate testdose facilitating a swift and more optimal titration process.
Keywords: ADHD; Computerised testing; Drug effects; Hyperkinetic disorders; Methylphenidate.
© 2011 The Authors. Child and Adolescent Mental Health © 2011 Association for Child and Adolescent Mental Health.
References
-
- Barkley, R.A. (1991). The ecological validity of laboratory and analogue assessment methods of ADHD symptoms. Journal of Abnormal Child Psychology, 19, 149-178.
-
- Conners, C.K. (1999). Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatric Clinics of North America, 46, 857-870.
-
- Gonzales, M.A., Pentikis, H.S., Anderl, N., Benedict, M.F., DeCory, H.H., Dirksen, S.J., & Hatch, S.J. (2002). Methylphenidate bioavailability from two extended-release formulations. International Journal of Clinical Pharmacology and Therapeutics, 40, 175-184.
-
- Goodman, R., Ford, T., Simmons, H., Gatward, R., & Meltzer, H. (2000). Using the Strenghts and Difficulties Questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. British Journal of Psychiatry, 177, 543-539.
-
- Hale, J.B., Fiorello, C.A., & Brown, L.L. (2005). Determining medication treatment effects using teacher ratings and classroom observations of children with ADHD: Does neuropsychological impairment matter ?. Educational and Child Psychology, 22, 39-61.
LinkOut - more resources
Full Text Sources